SCHEMBL21044072

SCHEMBL21044072

COC(=O)C1(c2csc(Br)n2)CCCC1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 6/20 0.39
▸ HDAC4 P56524 8/20 0.36
▸ HDAC3 O15379 2/20 0.36
▸ HDAC7 Q8WUI4 2/20 0.36
▸ HDAC2 Q92769 2/20 0.36
▸ HDAC10 Q969S8 2/20 0.36
▸ HDAC11 Q96DB2 2/20 0.36
▸ HDAC8 Q9BY41 2/20 0.36
▸ HDAC6 Q9UBN7 2/20 0.36
▸ HDAC9 Q9UKV0 2/20 0.36
▸ HDAC5 Q9UQL6 2/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ MEN1 O00255 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ BACE1 P56817 1/20 0.33
▸ ADORA1 P30542 1/20 0.32
▸ HRH3 Q9Y5N1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22869122 0.87 PDE5A (0.38) HDAC1HDAC4HDAC3HDAC7HDAC2
SCHEMBL14215419 0.85 HDAC1 (0.36) HDAC1NPSR1GAAMEN1MAPK1
SCHEMBL5516039 0.81 TLR7 (0.36) HDAC1HDAC4NPSR1GAAMEN1
SCHEMBL5169008 0.78 MEN1 (0.51) NPSR1MEN1MAPK1KMT2A
SCHEMBL20640304 0.77 MEN1 (0.50) MEN1MAPK1KMT2ABACE1
SCHEMBL27635825 0.76 MEN1 (0.33) HDAC1HDAC4HDAC3HDAC7HDAC2
SCHEMBL21076997 0.76 RAB9A (0.34) HDAC1NPSR1GAAHRH3
SCHEMBL21076995 0.74 CTPS1 (0.41) NPSR1
SCHEMBL22490785 0.74 PDE5A (0.39) HDAC1HDAC4HDAC3HDAC7HDAC2
SCHEMBL2588976 0.70 LMNA (0.35) HDAC4NPSR1GAAMEN1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3717459-B1 COMPOUNDS STEP PHARMA S A S (FR) 2026-01-21 — — EP disclosed
US-12503466-B2 Aminothiazole compounds as inhibitors of CTPS1 STEP PHARMA S.A.S. (FR) 2025-12-23 — — US disclosed
US-20240010645-A1 Aminothiazole Compounds as Inhibitors of CTPS1 STEP PHARMA S.A.S. (FR) 2024-01-11 — — US disclosed
US-11655246-B2 Aminothiazole compounds as inhibitors of CTPS1 STEP PHARMA S.A.S. (FR) 2023-05-23 — — US disclosed
US-20210002269-A1 COMPOUNDS STEP PHARMA S.A.S. (FR) 2021-01-07 — — US disclosed
EP-3717459-A1 COMPOUNDS Step Pharma S.A.S. (FR) 2020-10-07 — — EP disclosed
EP-3492454-A1 COMPOUNDS Step Pharma S.A.S. (FR) 2019-06-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12503466-B2 Aminothiazole compounds as inhibitors of CTPS1 CTPS1, CTPS2, TBXAS1 HDAC1 2381/4885HDAC4 3486/4885HDAC3 2940/4885
US-11655246-B2 Aminothiazole compounds as inhibitors of CTPS1 CTPS1, CTPS2, TBXAS1 HDAC1 2381/4885HDAC4 3486/4885HDAC3 2940/4885
US-20210002269-A1 COMPOUNDS UGT1A1, CYP1A1, CYP19A1 HDAC1 507/4885HDAC4 2460/4885HDAC3 715/4885
US-20240010645-A1 Aminothiazole Compounds as Inhibitors of CTPS1 CTPS1, CTPS2, TBXAS1 HDAC1 2381/4885HDAC4 3486/4885HDAC3 2940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback